Prosperity Financial Group, Inc. Affimed N.V. Call Options Transaction History

Prosperity Financial Group, Inc.

0 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form

No transaction found.

1.09M

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $520M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

Get notified when there are updates to the investment portfolio of Prosperity Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Prosperity Financial Group, Inc. with notifications on news.